GIMEDICAL · SERVICE

Re-export of Unregistered Medicines and PLAMMS

When an unregistered medicine is proposed for re-export through Hong Kong, PLAMMS applicability may be assessed under Drug Office rules. Applicant eligibility, documentation and the required licence for each shipment still need case-by-case confirmation.

Request a Re-export Feasibility Assessment
Re-export of Unregistered Medicines and PLAMMS

Relevant institutions

Pharmaceutical businessesLicensed import and distribution institutions
Content review: 2026-08-25 · Hong Kong Medicines and Regulatory Lead

CAPABILITIES

How we can assist

01

Hong Kong licensing feasibility assessment

02

Licensed wholesale handling

03

Storage and temperature-control coordination

04

Re-export documentation coordination

INFORMATION CHECKLIST

Prepare before assessment

  • 01Complete product name, dosage form, strength and pack
  • 02Target market version, manufacturer and estimated quantity
  • 03Business purpose, destination and preferred timing
  • 04Shelf life, storage, transport and document requirements

HOW IT RUNS

From sourcing to delivery

  1. 01Frame the requirement

    Align on name, version, quantity, purpose and destination.

  2. 02Verify product and source

    Check the supplier, licences and product documents.

  3. 03Assess licences and route

    Confirm import/export licensing, temperature and transport.

  4. 04Confirm in writing, then ship

    Quotation, shelf life and delivery terms on paper first.

READ BEFORE ENQUIRING

Conditions requiring case-by-case confirmation

  • A WDL is not a universal permit to import or export any medicine
  • Hong Kong licensing does not guarantee import approval at the destination
  • Re-export must not automatically be described as a transhipment exemption

NEXT STEP

Request a Re-export Feasibility Assessment

Start a business enquiry